Market Place
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 2Dr. Reddy's Laboratories
02 1Chongqing Carelife Pharmaceutical
03 1Hetero Drugs
04 2MSN Laboratories
05 2Olon S.p.A
06 1Shilpa Medicare
07 1Sun Pharmaceutical Industries Limited
01 1LENVATINIB MESILATE NON STERILE BULK DRUG SUBSTANCE
02 5LENVATINIB MESYLATE
03 1LENVATINIB MESYLATE (FORM-C)
04 1LENVATINIB MESYLATE (MIBK SOLVATE)
05 1LENVATINIB MESYLATE [ROUTE CODE JC]
06 1Lenvatinib Mesylate form C
01 1China
02 7India
03 2Italy
01 10Active
01 7Complete
02 3Blank
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2018-10-24
Pay. Date : 2018-08-09
DMF Number : 32905
Submission : 2018-06-26
Status : Active
Type : II
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2021-11-30
Pay. Date : 2021-11-08
DMF Number : 36031
Submission : 2021-06-30
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2022-01-24
Pay. Date : 2021-12-16
DMF Number : 36197
Submission : 2021-12-22
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39887
Submission : 2024-04-30
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2023-03-31
Pay. Date : 2023-03-17
DMF Number : 35779
Submission : 2021-03-29
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2019-03-25
Pay. Date : 2018-11-19
DMF Number : 33017
Submission : 2018-08-07
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37347
Submission : 2022-07-28
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 33964
Submission : 2019-06-27
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2018-11-20
Pay. Date : 2018-09-04
DMF Number : 33083
Submission : 2018-09-04
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2019-03-27
Pay. Date : 2018-12-12
DMF Number : 33331
Submission : 2019-02-04
Status : Active
Type : II
We have 7 companies offering Lenvatinib Mesylate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
